AstraZeneca boosts pharmacy stock of Brilinta
AstraZeneca is kicking off a program with more than 26,000 national, regional and independent pharmacies to ramp up retail availability of Brilinta, an anticoagulant. The drug maker said Tuesday that the U.S.